Mortality of epilepsy in developed countries: A review

Mortality in people with epilepsy has been studied in many different populations. In population-based incidence cohorts of epilepsy with 7-29 years follow-up, there was up to a threefold increase in mortality, compared to the general population (standardized mortality ratios [SMR] ranged from 1.6 to...

Full description

Bibliographic Details
Main Authors: Forsgren, L, Hauser, WA, Olafsson, E, Sander, JWAS, Sillanpää, M, Tomson, T
Format: Article in Journal/Newspaper
Language:unknown
Published: 2005
Subjects:
Online Access:http://discovery.ucl.ac.uk/1349668/
id ftucl:oai:eprints.ucl.ac.uk.OAI2:1349668
record_format openpolar
spelling ftucl:oai:eprints.ucl.ac.uk.OAI2:1349668 2023-05-15T16:52:39+02:00 Mortality of epilepsy in developed countries: A review Forsgren, L Hauser, WA Olafsson, E Sander, JWAS Sillanpää, M Tomson, T 2005-12-01 http://discovery.ucl.ac.uk/1349668/ unknown Epilepsia , 46 (SUPPL. 1) pp. 18-27. (2005) Article 2005 ftucl 2017-06-15T22:09:36Z Mortality in people with epilepsy has been studied in many different populations. In population-based incidence cohorts of epilepsy with 7-29 years follow-up, there was up to a threefold increase in mortality, compared to the general population (standardized mortality ratios [SMR] ranged from 1.6 to 3.0). When studies include selected epilepsy populations where patients with frequent and severe seizures are more common, the mortality is even greater. Relative survivorship (RS) following the diagnosis of epilepsy was 91%, 85%, and 83% after 5, 10, and 15 years, respectively. In a population with childhood-onset epilepsy, RS was 94% and 88% after 10 and 20 years. The level of increased mortality is affected by several factors. In idiopathic epilepsy where the causes of seizures are unknown, the results are conflicting. There was no significant increase in mortality in studies from Iceland, France, and Sweden, a barely increased risk in a study from the United Kingdom, and a significantly increased risk in a study from the United States. In contrast, all studies report a significant increased mortality in remote symptomatic epilepsy (standardized mortality ratios [SMRs] ranging from 2.2 to 6.5). The highest mortality is found in patients with epilepsy and neurodeficits present since birth, including mental retardation or cerebral palsy (SMRs ranging from 7 to 50). Mortality is also affected by age, with the highest SMRs in children, the combined effect of low mortality in the reference population, and high mortality in children with neurodeficits and epilepsy. The highest excess mortality is found in the elderly, ≥75 years. A pronounced increase in mortality is found during the first year following the onset of seizures due to underlying severe diseases. The increased mortality remains in different studies 2-14 years following diagnosis. Most of the factors responsible for the increased mortality are related to the underlying disorder causing epilepsy with pneumonia, cerebrovascular disease, and neoplastic disorders (risk remains elevated when primary brain tumors are excluded), as the most frequently recorded causes. The most common direct seizure-related cause of death in adolescents and young adults is sudden unexpected death, which is 24 times more common than in the general population. © 2005 International League Against Epilepsy. Article in Journal/Newspaper Iceland University College London: UCL Discovery
institution Open Polar
collection University College London: UCL Discovery
op_collection_id ftucl
language unknown
description Mortality in people with epilepsy has been studied in many different populations. In population-based incidence cohorts of epilepsy with 7-29 years follow-up, there was up to a threefold increase in mortality, compared to the general population (standardized mortality ratios [SMR] ranged from 1.6 to 3.0). When studies include selected epilepsy populations where patients with frequent and severe seizures are more common, the mortality is even greater. Relative survivorship (RS) following the diagnosis of epilepsy was 91%, 85%, and 83% after 5, 10, and 15 years, respectively. In a population with childhood-onset epilepsy, RS was 94% and 88% after 10 and 20 years. The level of increased mortality is affected by several factors. In idiopathic epilepsy where the causes of seizures are unknown, the results are conflicting. There was no significant increase in mortality in studies from Iceland, France, and Sweden, a barely increased risk in a study from the United Kingdom, and a significantly increased risk in a study from the United States. In contrast, all studies report a significant increased mortality in remote symptomatic epilepsy (standardized mortality ratios [SMRs] ranging from 2.2 to 6.5). The highest mortality is found in patients with epilepsy and neurodeficits present since birth, including mental retardation or cerebral palsy (SMRs ranging from 7 to 50). Mortality is also affected by age, with the highest SMRs in children, the combined effect of low mortality in the reference population, and high mortality in children with neurodeficits and epilepsy. The highest excess mortality is found in the elderly, ≥75 years. A pronounced increase in mortality is found during the first year following the onset of seizures due to underlying severe diseases. The increased mortality remains in different studies 2-14 years following diagnosis. Most of the factors responsible for the increased mortality are related to the underlying disorder causing epilepsy with pneumonia, cerebrovascular disease, and neoplastic disorders (risk remains elevated when primary brain tumors are excluded), as the most frequently recorded causes. The most common direct seizure-related cause of death in adolescents and young adults is sudden unexpected death, which is 24 times more common than in the general population. © 2005 International League Against Epilepsy.
format Article in Journal/Newspaper
author Forsgren, L
Hauser, WA
Olafsson, E
Sander, JWAS
Sillanpää, M
Tomson, T
spellingShingle Forsgren, L
Hauser, WA
Olafsson, E
Sander, JWAS
Sillanpää, M
Tomson, T
Mortality of epilepsy in developed countries: A review
author_facet Forsgren, L
Hauser, WA
Olafsson, E
Sander, JWAS
Sillanpää, M
Tomson, T
author_sort Forsgren, L
title Mortality of epilepsy in developed countries: A review
title_short Mortality of epilepsy in developed countries: A review
title_full Mortality of epilepsy in developed countries: A review
title_fullStr Mortality of epilepsy in developed countries: A review
title_full_unstemmed Mortality of epilepsy in developed countries: A review
title_sort mortality of epilepsy in developed countries: a review
publishDate 2005
url http://discovery.ucl.ac.uk/1349668/
genre Iceland
genre_facet Iceland
op_source Epilepsia , 46 (SUPPL. 1) pp. 18-27. (2005)
_version_ 1766043023022489600